1260422-02-3

Basic information

• Product Name: 5-(4-bromo-2-methoxyphenyl)-2-methyl-1,3-oxazole
• Synonyms: 5-(4-bromo-2-methoxyphenyl)-2-methyl-1,3-oxazole;5-(4-Bromo-2-Methoxy-Phenyl)-2-Methyl-Oxazole;5-(4-Bromo-2-Methoxy-Phenyl)-2-Methyl-Oxazole(WX633113)
• CAS NO: 1260422-02-3
• Molecular Formula: C₁₁H₁₀BrNO₂
• Molecular Weight: 268.1066
• EINECS: -0
• Mol File: 1260422-02-3.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-(4-bromo-2-methoxyphenyl)-2-methyl-1,3-oxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-bromo-2-methoxyphenyl)-2-methyl-1,3-oxazole(1260422-02-3)
• EPA Substance Registry System: 5-(4-bromo-2-methoxyphenyl)-2-methyl-1,3-oxazole(1260422-02-3)

Safety Data

• Hazardous Substances Data: 1260422-02-3(Hazardous Substances Data)

Usage

Structure

It belongs to the oxazole family, comprising a five-membered heterocyclic ring with one oxygen and one nitrogen atom.

Biological Activities

Antimicrobial: Exhibits activity against various microorganisms.
Antifungal: Demonstrates effectiveness against fungal infections.
Anti-inflammatory: Displays anti-inflammatory properties, potentially useful for treating inflammatory conditions.

Medical and Pharmaceutical Research

Widely utilized in medicinal and pharmaceutical research due to its diverse biological activities.

Drug Candidate

Investigated as a potential drug candidate for various diseases, indicating therapeutic potential.

Organic Synthesis

Utilized in organic synthesis processes.

Building Block

Acts as a building block in the design and synthesis of new chemical entities with potential therapeutic applications.

Upstream product

• 1260424-09-6 5-(4-bromo-2-fluorophenyl)-2-methyl-1,3-oxazole 
• 124-41-4 sodium methylate 
• 801303-33-3 4-bromo-2-fluoro-N-methoxy-N-methylbenzamide 
• 625446-22-2 4-bromo-2-fluoroacetophenone 
• 112704-79-7 2-fluoro-4-bromobenzoic acid 

Downstream Products

• 1363149-07-8 5-(4-(5-chloropent-1-yn-1-yl)-2-methoxyphenyl)-2-methyloxazole 
• 1363149-11-4 ethyl 2-amino-7-[3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)phenyl]hept-6-ynoate 
• 1262106-81-9 3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)benzoic acid 
• 1262106-84-2 tert-butyl 2-{[3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)phenyl]carbonyl}hydrazinecarboxylate 
• 1262106-82-0 methyl 3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)benzoate 
• 1262106-21-7 8-(3,4-dichlorophenyl)-2-[3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)phenyl]-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyridine 
• 1262190-47-5 3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)benzohydrazide 
• 1262106-83-1 3-methoxy-4-(2-methyl-1,3-oxazol-5-yl)benzohydrazide hydrochloride 
• 1363149-15-8 ethyl 2-azido-7-(3-methoxy-4-(2-methyloxazol-5-yl)phenyl)hept-6-ynoate 

Relevant articles and documents

HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and use thereof. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.